Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

JonesTrading analyst Debanjana Chatterjee has reiterated their bullish stance on NTLA stock, giving a Buy rating on November 13. Debanjana ...

Leading the Way in Specialized Diabetic Foot Care in Delhi NCRDelhi, India - November 17, 2024 — Diabetes, often called the ...

Clene (NASDAQ:CLNN – Free Report) had its price target cut by Canaccord Genuity Group from $86.00 to $83.00 in a research report released on Thursday morning,Benzinga reports. They currently have a ...

completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial ...

Unexpected cardiovascular complications: Manipulating the neck can sometimes affect blood flow and lead to unexpected ...

Come out and audition and experience the fun of community theater in Carson City on Tuesday, Nov. 19 at 6 p.m. and Saturday, ...

Medically reviewed by Katrina Carter, DPT Reflexology is a complementary and alternative medicine (CAM) therapy. It's a type ...

As our mutual friend Mark Twain reminds us around this time of year, “The Christmas holidays have this high value: that they ...

"Zero Candida has a potential to become a technological leader and use its ground-breaking technology to expand boundaries of non-chemical candida treatment," added Mr ... biologic therapy to treat ...

Completed Enrollment of Dose Escalation Part of Phase 1 Clinical Trial of its Next-Generation Nectin-4 Targeting ADC (CRB-701 ...